Literature DB >> 25854492

Pediatric antiphospholipid syndrome.

Cassyanne L Aguiar1, Arzu Soybilgic, Tadej Avcin, Barry L Myones.   

Abstract

Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS. The purpose of this report is to review the current literature on APS in children and neonates, identify the gaps in current knowledge, and suggest avenues for studies to fill those gaps.

Entities:  

Mesh：

Year:  2015        PMID： 25854492     DOI： 10.1007/s11926-015-0504-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  129 in total

1.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.

Authors:  Azzudin E Gharavi; Silvia S Pierangeli; Ricardo G Espinola; Xiaowei Liu; Margaret Colden-Stanfield; E Nigel Harris
Journal:  Arthritis Rheum       Date:  2002-02

3.  Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2)glycoprotein-I antibodies in a healthy infant population.

Authors:  Javier Cabiedes; Jorge Trejo-Hernández; Arturo Loredo-Abdalá; Luis Castilla-Serna; A Tamara López-Mendoza; Hugo A Cordero-Esperón; M Teresa Huerta; Antonio R Cabral; Donato Alarcón-Segovia
Journal:  Arch Med Res       Date:  2002 Mar-Apr       Impact factor: 2.235

4.  Anticardiolipin response in acute infections.

Authors:  O Vaarala; T Palosuo; M Kleemola; K Aho
Journal:  Clin Immunol Immunopathol       Date:  1986-10

Review 5.  Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology.

Authors:  Giovanni Sanna; Maria Laura Bertolaccini; Graham R V Hughes
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 6.  Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.

Authors:  Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Autoimmun Rev       Date:  2010-08-07       Impact factor: 9.754

Review 7.  Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.

Authors:  T Avcin; R Cimaz; P L Meroni
Journal:  Lupus       Date:  2002       Impact factor: 2.911

Review 8.  Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease.

Authors:  Cassyanne L Aguiar; Doruk Erkan
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

9.  Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Authors:  Steven R Levine; Robin L Brey; Barbara C Tilley; J L P Thompson; Ralph L Sacco; Robert R Sciacca; A Murphy; Yimeng Lu; Teresa M Costigan; Candi Rhine; Bruce Levin; Douglas A Triplett; J P Mohr
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

10.  A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus.

Authors:  Tadej Avcin; Susanne M Benseler; Pascal N Tyrrell; Sasa Cucnik; Earl D Silverman
Journal:  Arthritis Rheum       Date:  2008-02-15
View more
  12 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

2.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

3.  Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.

Authors:  Rakesh Kumar Pilania; Deepti Suri; Ankur Kumar Jindal; Narender Kumar; Avinash Sharma; Praveen Sharma; Sandesh Guleria; Amit Rawat; Jasmina Ahluwalia; Surjit Singh
Journal:  Rheumatol Int       Date:  2018-08-11       Impact factor: 3.580

Review 4.  Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners?

Authors:  Donato Rigante; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

Review 5.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

Review 6.  Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.

Authors:  Silvia Rosina; Cecilia Beatrice Chighizola; Angelo Ravelli; Rolando Cimaz
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

Review 7.  Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.

Authors:  Aline Garcia Islabão; Vitor Cavalcanti Trindade; Licia Maria Henrique da Mota; Danieli Castro Oliveira Andrade; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-12-13       Impact factor: 3.022

8.  Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.

Authors:  Jacqueline A Madison; Kelsey Gockman; Claire Hoy; Ajay Tambralli; Yu Zuo; Jason S Knight
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-23       Impact factor: 3.054

9.  Pediatric Deep Venous Thrombosis and Pulmonary Embolism: Can It Be Antiphospholipid Syndrome?

Authors:  Fatma Demir Yenigürbüz; Hale Ören
Journal:  Turk J Haematol       Date:  2018-09-11       Impact factor: 1.831

10.  Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.

Authors:  Claudia Brogna; Marco Luigetti; Giulia Norcia; Roberta Scalise; Gloria Ferrantini; Beatrice Berti; Domenico M Romeo; Raffaele Manna; Eugenio Mercuri; Marika Pane
Journal:  Brain Sci       Date:  2020-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.